Literature DB >> 9771438

Classification of acute leukaemia: the need to incorporate cytogenetic and molecular genetic information.

B J Bain1.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9771438      PMCID： PMC500742          DOI： 10.1136/jcp.51.6.420

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  21 in total

1.  All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.

Authors:  J D Rowley; S Reshmi; O Sobulo; T Musvee; J Anastasi; S Raimondi; N R Schneider; J C Barredo; E S Cantu; B Schlegelberger; F Behm; N A Doggett; J Borrow; N Zeleznik-Le
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

Review 2.  Molecular biology of acute myeloid leukemia.

Authors:  M A Caligiuri; M P Strout; D G Gilliland
Journal:  Semin Oncol       Date:  1997-02       Impact factor: 4.929

Review 3.  Clinical significance of cytogenetics in acute myeloid leukemia.

Authors:  K Mrózek; K Heinonen; A de la Chapelle; C D Bloomfield
Journal:  Semin Oncol       Date:  1997-02       Impact factor: 4.929

4.  The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10.

Authors:  Y Arai; F Hosoda; H Kobayashi; K Arai; Y Hayashi; N Kamada; Y Kaneko; M Ohki
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

5.  Clinical, haematological and molecular studies in patients with chromosome translocation t(7;11): a study of four Chinese patients in Taiwan.

Authors:  S Y Huang; J L Tang; Y J Liang; C H Wang; Y C Chen; H F Tien
Journal:  Br J Haematol       Date:  1997-03       Impact factor: 6.998

6.  The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene.

Authors:  T Taki; M Sako; M Tsuchida; Y Hayashi
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

7.  Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials. MRC Adult Leukaemia Working Party.

Authors:  S E Langabeer; H Walker; J R Rogers; A K Burnett; K Wheatley; D Swirsky; A H Goldstone; D C Linch
Journal:  Br J Haematol       Date:  1997-12       Impact factor: 6.998

8.  Frequency of CBF beta/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. The MRC Adult Leukaemia Working Party.

Authors:  S E Langabeer; H Walker; R E Gale; K Wheatley; A K Burnett; A H Goldstone; D C Linch
Journal:  Br J Haematol       Date:  1997-03       Impact factor: 6.998

9.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

10.  Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Ann Intern Med       Date:  1985-09       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.